The DOI matches its Crossref record; 89 of the 90 references it cites were found in a registry or an index; none of the 86 sources its claims cite is checked for support yet.
Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies
Abstract
Aims/hypothesis We systematically reviewed and summarised prospective data relating diabetes status to changes in cognitive function over time.Methods Published reports of longitudinal studies that described assessment of cognitive function in people with diabetes were sought. Studies were included if they assessed cognitive function in participants with diabetes at the beginning and at follow-up. Studies were excluded if they had (1) a follow-up period of less than 1 year, (2) a rate of loss to follow-up in excess of 30%, or (3) described selected subgroups. Change in cognitive function was recorded as either the mean change in score and/or the proportion of individuals developing various degrees of change in cognitive function. A pooled estimate was calculated for the latter.Results Of 1,165 abstracts and titles initially identified, 25 articles met the inclusion and exclusion criteria. Individuals with diabetes had a 1.2- to 1.5-fold greater change over time in measures of cognitive function than those without diabetes. When assessed by the Mini-Mental State Exam and the Digit Symbol Span tests, a diagnosis of diabetes increased the odds of cognitive decline 1.2-fold (95% CI 1.05-1.4) and 1.7-fold (95% CI 1.3-2.3), respectively . The odds of future dementia increased 1.6-fold (95% CI 1.4-1.8).Conclusions/interpretation Compared to people without diabetes, people with diabetes have a greater rate of decline in cognitive function and a greater risk of cognitive decline. Cognitive dysfunction should therefore be added to the list of chronic complications of diabetes.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This systematic overview of 25 prospective observational studies found that people with diabetes have greater cognitive decline and a higher risk of dementia than people without diabetes. The authors conclude that cognitive dysfunction should be added to the list of chronic complications of diabetes.
Key findings
- Among 25 included articles covering more than 8,656 people with diabetes and follow-up periods of 2 to 18 years, diabetes was associated with a 1.2- to 1.5-fold greater change over time in measures of cognitive function.
- Pooled estimates showed increased odds of cognitive decline on the MMSE/3MS (OR 1.2, 95% CI 1.05–1.4) and DSS (OR 1.7, 95% CI 1.3–2.3), and a 1.6-fold higher risk of future all-cause dementia (95% CI 1.4–1.8).
- For dementia subtypes, risks ranged from 1.2 to 2.3 for Alzheimer’s disease and from 2.2 to 3.4 for vascular dementia.
- In continuous DSS analyses, three studies reported a decline of 1.3 to 1.4% per year in people with diabetes; overall this decline was up to 1.5 times greater than in people without diabetes.
Methods
- Systematic review of longitudinal/prospective observational studies; Medline, EMBASE, and PsycINFO were searched, along with expert contact and bibliography review. Of 1,165 abstracts/titles, 50 were fully reviewed and 25 met inclusion/exclusion criteria.
- Inclusion required baseline and follow-up cognitive assessment, diabetes or glucose tolerance status, and English-language reporting; exclusions were follow-up under 1 year, loss to follow-up over 30%, or selected subgroups.
- Data were abstracted on age, diabetes definition, participant numbers, follow-up length, cognitive tools, and outcomes; pooled inverse variance-weighted log risk ratios with 95% CIs were calculated, with heterogeneity assessed by the Q statistic using Review Manager 4.2.
Limitations
- The paper states possible publication bias, though it argues this is unlikely because many included studies were prospective cohorts examining many risk factors; it also states that MMSE/3MS may underestimate diabetes effects because it poorly detects attention and processing speed.
- The paper states that included studies differed in definitions of clinically meaningful decline, diabetes identification, age groups, cognitive tools, statistical adjustment, baseline cognitive impairment, and follow-up completeness (73–92%), and that there is no evidence to date that diabetes management affects the rate or nature of cognitive dysfunction.
- Evident from the text: only three studies explicitly reported that data were collected without examiner awareness of diabetes status, and some pooled estimates relied on few studies, such as the DSS estimate based on two studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
34 Not checked yet · 23 Own result · 6 Own interpretation · 4 Own method · 1 No basis given
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Individuals with diabetes had a 1.2- to 1.5-fold greater change over time in measures of cognitive function than those without diabetes.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The odds of future dementia increased 1.6-fold (95% CI 1.4 -1.8).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The definitions of dementia used in the included studies are sufficiently comparable to be combined in the review.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When assessed by the Mini-Mental State Exam and the Digit Symbol Span tests, a diagnosis of diabetes increased the odds of cognitive decline 1.2-fold (95% CI 1.05 -1.4) and 1.7-fold (95% CI 1.3 -2.3), respectively.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The 25 remaining articles [46 -70] comprised data from more than 8,656 people with diabetes, with follow-up periods ranging from 2 to 18 years.”
What the sources say
- Not checked yetcites [46 -70]
plainn = 8,656- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When assessed by the Mini-Mental State Exam and the Digit Symbol Span tests, a diagnosis of diabetes increased the odds of cognitive decline 1.2-fold (95% CI 1.05 -1.4) and 1.7-fold (95% CI 1.3 -2.3), respectively.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“However, in contrast to the acute negative effect of hypoglycaemia on cognition, there is little evidence to support chronic cognitive impairment secondary to hypoglycaemia.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Compared to people without diabetes, people with diabetes were 1.2 times more likely to experience cognitive decline as measured by the MMSE/3MS (95% CI 1.0 -1.4) and 1.7 times more likely to experience cognitive decline as measured by the DSS (95% CI 1.3 -2.3).”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The cognitive assessment instruments used across the included studies measure cognitive decline in a comparable way.
None of the sources cited for this claim have been checked yet.
In the paper
“Table 2 lists the six studies that reported time-related changes as a continuous variable using either the MMSE or 3MS score in individuals with and without a history of diabetes [49, 51, 52, 54, 65, 69].”
What the sources say
- Not checked yetcites [49] Wu JH, Haan MN, Liang J, Ghosh D, Gonzalez HM, Herman WH (2003) Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study. Ann Epidemiol 13:369–376 source
- Not checked yetcites [51] Fontbonne A, Berr C, Ducimetiere P, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24:366–370 source
- Not checked yetcites [52] Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L (1999) The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 282:40–46 source
- Not checked yetcites [54] Gregg EW, Yaffe K, Cauley JA et al (2000) Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 160:174–180 source
- Not checked yetcites [65] Hassing LB, Hofer SM, Nilsson SE et al (2004) Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing 33:355–361 source
- Not checked yetcites [69] Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K (2004) Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164:1327–1333 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In these studies, diabetes status predicted an odds ratio for cognitive decline that ranged from 0.7 to 4.4.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The cognitive assessment instruments used across the included studies measure cognitive decline in a comparable way.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Three studies reported a decline ranging from 1.3 to 1.4% per year in people with diabetes.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Probably not a substantial claim. 12
- It may state two separate claims as one. 17
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of 1,165 abstracts and titles initially identified, 25 articles met the inclusion and exclusion criteria.”
- Also stated in: § Search · p. 3 · plain
“The 25 remaining articles [46 -70] comprised data from more than 8,656 people with diabetes, with follow-up periods ranging from 2 to 18 years.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
- Also stated in: § Search · p. 3 · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of these citations, 50 met the inclusion criteria and were fully reviewed and analysed.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The 25 remaining articles [46 -70] comprised data from more than 8,656 people with diabetes, with follow-up periods ranging from 2 to 18 years.”
plainn = 8,656- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Table 3, and Figs. 1 and 2 list and display results from the six studies that used the MMSE or 3MS [47 -51, 54, 62, 69] and the two studies that used the DSS [51, 54] to classify participants into those who did and did not experience cognitive decline.”
What the sources say
- Not checked yetcites [47] Nguyen HT, Black SA, Ray LA, Espino DV, Markides KS (2002) Predictors of decline in MMSE scores among older Mexican Americans. J Gerontol A Biol Sci Med Sci 57:M181–M185 source
- Not checked yetcites [48] Wu JH, Haan MN, Liang J, Ghosh D, Gonzalez HM, Herman WH (2003) Impact of diabetes on cognitive function among older Latinos: a population-based cohort study. J Clin Epidemiol 56:686–693 source
- Not checked yetcites [49] Wu JH, Haan MN, Liang J, Ghosh D, Gonzalez HM, Herman WH (2003) Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study. Ann Epidemiol 13:369–376 source
- Not checked yetcites [50] Haan MN, Mungas DM, Gonzalez HM, Ortiz TA, Acharya A, Jagust WJ (2003) Prevalence of dementia in older Ltinos: the influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Geriat Soc 51:169–177 source
- Not checked yetcites [51] Fontbonne A, Berr C, Ducimetiere P, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24:366–370 source
- Not checked yetcites [54] Gregg EW, Yaffe K, Cauley JA et al (2000) Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 160:174–180 source
- Not checked yetcites [62] Stewart R, Prince M, Mann A (2003) Age, vascular risk, and cognitive decline in an older, British, African-Caribbean population. J Am Geriat Soc 51:1547–1553 source
- Not checked yetcites [69] Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K (2004) Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164:1327–1333 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
In the paper
“However, one study reported an improvement in score of 1.2% in people with diabetes; nevertheless this improvement was approximately half of the improvement experienced by the non-diabetic participants [51].”
What the sources say
- Not checked yetcites [51] Fontbonne A, Berr C, Ducimetiere P, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24:366–370 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Four studies used the DSS as a continuous variable (Table 2) to assess cognitive function and three reported an adverse effect of diabetes on cognitive function over time.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Five of these studies reported that participants with diabetes had a higher risk of developing cognitive decline than those without diabetes; in three of these the lower limit of the 95% confidence interval exceeded 1 (i.e. it was statistically significant).”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: The definitions of dementia used in the included studies are sufficiently comparable to be combined in the review.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Seventeen studies divided the participants into two groups based on whether or not participants did or did not experience cognitive decline during follow-up.”
plainn = 17- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Eight studies reported a variety of other cognitive tests, most of them reporting greater or equal cognitive change for the diabetic participants (Table 1) [46, 49, 51, 58, 63, 66, 69, 70]. Some, but not all of the tests detected a significant difference between the groups with and without diabetes.”
What the sources say
- Not checked yetcites [46] Logroscino G, Kang JH, Grodstein F (2004) Prospective study of type 2 diabetes and cognitive decline in women aged 70–81 years. BMJ 328:548 source
- Not checked yetcites [49] Wu JH, Haan MN, Liang J, Ghosh D, Gonzalez HM, Herman WH (2003) Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study. Ann Epidemiol 13:369–376 source
- Not checked yetcites [51] Fontbonne A, Berr C, Ducimetiere P, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24:366–370 source
- Not checked yetcites [58] Leibson CL, Rocca WA, Hanson VA et al (1997) Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 145:301–308 source
- Not checked yetcites [63] Robertson-Tchabo EA, Arenberg D, Tobin JD, Plotz JB (1986) A longitudinal study of cognitive performance in noninsulin dependent (type II) diabetic men. Exp Gerontol 21:459–467 source
- Not checked yetcites [66] Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61:661–666 source
- Not checked yetcites [69] Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K (2004) Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164:1327–1333 source
- Not checked yetcites [70] Yaffe K, Blackwell T, Kanaya AM, Davidowitz BA, Barrett-Connor E, Krueger K (2004) Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63:658–663 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In these studies, individuals with diabetes had a greater absolute annual decline in score than those without diabetes; however, the differences only achieved statistical significance in one study [70].”
What the sources say
- Not checked yetcites [70] Yaffe K, Blackwell T, Kanaya AM, Davidowitz BA, Barrett-Connor E, Krueger K (2004) Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63:658–663 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The selected studies were analysed according to previously published methodological criteria [12] to determine if they reported: (1) a predetermined method for selection of the participants; (2) the definition of diabetes mellitus; (3) the definition of the outcome; (4) use of the same cognitive assessment instrument in the two groups; (5) that data were collected unaware of the diabetes status (b”
What the sources say
- Not checked yetcites [12] Horwitz RI, Feinstein AR (1979) Methodologic standards and contradictory results in case-control research. Am J Med 66:556–564 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Only three studies explicitly reported that data were collected without the examiner being aware of the diabetes status of the participant [46, 51, 62].”
What the sources say
- Not checked yetcites [46] Logroscino G, Kang JH, Grodstein F (2004) Prospective study of type 2 diabetes and cognitive decline in women aged 70–81 years. BMJ 328:548 source
- Not checked yetcites [51] Fontbonne A, Berr C, Ducimetiere P, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24:366–370 source
- Not checked yetcites [62] Stewart R, Prince M, Mann A (2003) Age, vascular risk, and cognitive decline in an older, British, African-Caribbean population. J Am Geriat Soc 51:1547–1553 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Heterogeneity was assessed using the Q statistic [20].”
What the sources say
- Not checked yetcites [20] Laird NM, Mosteller F (1990) Some statistical methods for combining experimental results. Int J Technol Assess Health Care 6:5–30 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“The validity of the MMSE as a screening tool for detecting dementia has been extensively studied [17]; its ability to detect changes in cognitive function for non-demented individuals has been documented mainly in the elderly [18].”
What the sources say
- Not checked yetcites [17] Tombaugh TN, McIntyre NJ (1992) The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40:922–935 source
- Not checked yetcites [18] Brayne C, Spiegelhalter DJ, Dufouil C et al (1999) Estimating the true extent of cognitive decline in the old. J Am Geriatr Soc 47:1283–1288 source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“ple with diabetes have a greater rate of decline in cognitive function and a greater risk of cognitive decline.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: The definitions of dementia used in the included studies are sufficiently comparable to be combined in the review.
- Rests on an assumption: The cognitive assessment instruments used across the included studies measure cognitive decline in a comparable way.
- Rests on an assumption: The included studies' participants with diabetes are representative of people with diabetes generally.
In the paper
“Compared to non-diabetic individuals, diabetes increased the risk of vascular dementia and Alzheimer ' s dementia 1.3 and 4.4-fold, respectively.”
What the sources say
- Not checked yetcites [72] Yamada M, Kasagi F, Sasaki H, Masunari N, Mimori Y, Suzuki G (2003) Association between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health Study. J Am Geriat Soc 51:410–414 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Experimental studies in animal models and in humans without diabetes have shown that poor glucose regulation after a glucose challenge test was associated with poorer performance on a variety of cognitive tests, the effect being more pronounced in the older age group [81].”
What the sources say
- Not checked yetcites [81] Messier C (2004) Glucose improvement of memory: a review. Eur J Pharmacol 490:33–57 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Another factor suggesting that the reports underestimated the effect of diabetes on cognitive decline is the fact that most of the studies did not include information on people who died or who were lost to follow-up, when follow-up success itself could well be linked to good cognitive function.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“These findings are supported by previous reviews of the available longitudinal studies [3, 4, 6].”
What the sources say
- Not checked yetcites [3] Allen KV, Frier BM, Strachan MW (2004) The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol 490:169–175 source
- Not checked yetcites [4] Areosa Sastre A, Grimley Evans J (2005) Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia. The Cochrane Library, Issue 2, http://www.cochrane.org/cochrane/revabstr/AB003804.htm
- Not checked yetcites [6] Stewart R, Liolitsa D (1999) Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 16:93–112 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Indeed, a recent review of the effect of therapy concluded that no studies were appropriate for inclusion in meta analysis [4].”
What the sources say
- Not checked yetcites [4] Areosa Sastre A, Grimley Evans J (2005) Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia. The Cochrane Library, Issue 2, http://www.cochrane.org/cochrane/revabstr/AB003804.htm
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“As these domains may be selectively impaired in people with diabetes the MMSE/3MS will underestimate the impact of diabetes on cognitive function [10].”
What the sources say
- Not checked yetcites [10] Strachan MW, Deary IJ, Ewing FM, Frier BM (1997) Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 20:438–445 source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The study is also limited by the differences in the studies included with respect to: (1) the definition of a clinically meaningful decline in cognitive function; (2) identification of people with and without diabetes; (3) age groups that were studied; (4) cognitive assessment tools employed; (5) degree of statistical adjustment for confounders; (6) degree of cognitive impairment permitted in stud”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In one study, this finding was only noted in young participants, while findings in older participants were consistent with the results from the other studies [62].”
What the sources say
- Not checked yetcites [62] Stewart R, Prince M, Mann A (2003) Age, vascular risk, and cognitive decline in an older, British, African-Caribbean population. J Am Geriat Soc 51:1547–1553 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“However, many of the studies analysed by us were prospective cohort studies, which examined many risk factors for cognitive decline, and not just diabetes. This makes it unlikely that a lack of an association with diabetes would lead to non-publication.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In the other study, this finding was only noted for women, and only in certain cognitive tests. The large confidence interval and wide variability of scores between tests reported in this study suggest that a larger sample size could possibly have altered the results [69].”
What the sources say
- Not checked yetcites [69] Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K (2004) Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164:1327–1333 source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper relies on this without support.
The definitions of dementia used in the included studies are sufficiently comparable to be combined in the review.
“The definition of dementia used in each study was accepted for this review.”
The paper relies on this without support.
The cognitive assessment instruments used across the included studies measure cognitive decline in a comparable way.
“Cognitive function was measured using a variety of simple cognitive tests [9, 13, 14].”
The paper relies on this without support.
The included studies' participants with diabetes are representative of people with diabetes generally.
“The 25 remaining articles [46 -70] comprised data from more than 8,656 people with diabetes, with follow-up periods ranging from 2 to 18 years.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Older adults with diabetes are at higher risk of cognitive decline and institutionalization (12,13).”
From 13. Older Adults: Standards of Care in Diabetes—2024 (2024) · cites this paper as [12]
Experimental — accuracy not yet measuredIn the citing paper
“Type 2 diabetes (T2D) has been demonstrated to be related to accelerated cognitive decline (3) and increased risk of dementia (4)”
From Type 2 Diabetes and Antidiabetic Medications in Relation to Dementia Diagnosis (2014) · cites this paper as [3]
In the citing paper
“Cross-sectional studies have shown an association between hyperglycemia and cognitive dysfunction62.”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [62]
In the citing paper
“Evidence for impairments in peripheral insulin signalling in patients with AD was presented more than 25 years ago, 138 and the incidence of AD is known to be increased in patients with metabolic impairments such as diabetes 139,140 ; fittingly, some cognitive domains have been consistently found to be affected in type 2 diabetes (eg, memory, psychomotor speed, executive function).113”
From Intranasal insulin (2021) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Total (95% CI) | 2723 | 10044 | 1.6 (1.4, 1.8) |”
Reported 10044 · recomputed 11497
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Measures of cognitive function · p. 5
“| Gregg et al [54] | 402 | 584 | 1.0 (0.8, 1.4) |”
§ Measures of cognitive function · p. 4
“| MMSE/3MS | [54] | 65 - 99 (F) | History | 6 | 402 | 5844 | ≥ 11.5% a | 1.0 (0.8 - 1.4) e |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Total (95% CI) | 2723 | 10044 | 1.6 (1.4, 1.8) |”
Reported 2723 · recomputed 3585
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,852
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,007
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
The Mini‐Mental State Examination: A Comprehensive Review
Tombaugh, T. N., & McIntyre, N. J. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb01992.x · Cited by 5,152
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
The Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926
Cited by
Sorted by citations
Items 501–600 of 998
Stantonyonge, N., Sampedro, F., Méndez, J., Martínez‐Horta, S., Chico, A. I., & Gómez‐Ansón, B. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa832 · Cited by 16
Hao, Y., Li, J., Yue, S., Wang, S., Hu, S., & Li, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.917375 · Cited by 17
“Multiple lines of evidence indicate that cognitive impairment is directly associated with DM and is a serious complication of diabetes (Cukierman et al., 2005; Biessels and Despa, 2018).”
BackgroundOgura, J., & Yamaguchi, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126542 · Cited by 19
Xin, H., Fu, Y., Feng, M., Wang, S., Sui, C., Gao, Y., Zhang, N., Guo, L., Wen, H., & Liang, C. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac651 · Cited by 18
Bariatric Surgery Improves Cognition Function in the Patients with Obesity: A Meta-Analysis
Tao, B., Tian, P., Hao, Z., Qi, Z., Zhang, J., Liu, J., Liu, J., Li, M., Zhang, Z., & Zhang, P. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07086-8 · Cited by 18
Liu, Z., Zaid, M., Hisamatsu, T., Tanaka, S., Fujiyoshi, A., Miyagawa, N., Ito, T., Kadota, A., Tooyama, I., Miura, K., et al. (2019) · Journal of Epidemiology · doi:10.2188/jea.je20180193 · Cited by 19
Adem, K. A., Shanti, A., Srivastava, A., Homouz, D., Thomas, S. A., Khair, M., Stefanini, C., Chan, V., Kim, T., & Lee, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.842582 · Cited by 17
“Ongoing research has established a strong association between AD and T2D in which patients of T2D were shown to be at a higher risk of developing AD (Cukierman et al., 2005; Biessels et al., 2006; Vagelatos and Eslick, 2013; Beeri and Bendlin, 2020) and vice versa (Janson et al.”
BackgroundWright, R. S., Levy, S.-A. T., Katzel, L. I., Rosenberger, W. F., Manukyan, Z., Whitfield, K. E., & Waldstein, S. R. (2015) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2014.985189 · Cited by 21
“Numerous studies have demonstrated evidence of reduced cognitive performance among older adults with Type 2 DM (Awad et al., 2004; Cukierman et al., 2005; Ryan, 2005).”
BackgroundAneke-Nash, C. S., Xue, X., Qi, Q., Biggs, M. L., Cappola, A. R., Kuller, L. H., Pollak, M., Psaty, B. M., Siscovick, D. S., Mukamal, K. J., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01273 · Cited by 17
Insulin Action in the Brain and the Pathogenesis of Alzheimer’s Disease
Kahn, C. R., & Suzuki, R. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-04300-0_1 · Cited by 17
“Longitudinal studies have revealed that patients with type 2 diabetes have a 1.5-fold greater change over time in measures of cognitive function than those without diabetes (Cukierman et al. 2005).”
BackgroundInfluentialChan, R. N. F., Tang, Z., Chan, V. T. T., Chan, R. N. C., Cheng, E. T. W., Ng, N. C. Y., & Cheung, C. Y.-L. (2022) · Eye · doi:10.1038/s41433-022-02033-2 · Cited by 17
Shima, T., Kawabata‐Iwakawa, R., Onishi, H., Jesmin, S., & Yoshikawa, T. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01117-y · Cited by 16
Unlocking the Potential: Millets and Their Impact on Diabetes Management
Ansar Ahamed, V. P., Joshi, A. U., Mudey, A. B., Choudhari, S. G., Raut, J. M., & Ahmed, S. (2024) · Cureus · doi:10.7759/cureus.59283 · Cited by 16
Xiu, L.-L., Wahlqvist, M. L., Lee, M., & Chen, R. C.-Y. (2013) · PubMed · doi:10.6133/apjcn.2013.22.4.20 · Cited by 16
Type 2 Diabetes and Memory: Using Neuroimaging to Understand the Mechanisms
Jones, N., Riby, L. M., Mitchell, R., & Smith, M. (2014) · Current Diabetes Reviews · doi:10.2174/1573399810666140425160811 · Cited by 16
“In addition to the accelerated cognitive decline observed in DM2, it is also reported that people with DM2 are at greater risk of dementia [2, 17].”
BackgroundKelly, A., Calamia, M. R., Koval, A., Terrera, G. M., Piccinin, A. M., Clouston, S., Hassing, L. B., Bennett, D. A., Johansson, B. E. A., & Hofer, S. M. (2016) · Psychology and Aging · doi:10.1037/pag0000078 · Cited by 18
Animal Research for Alzheimer Disease: Failures of Science and Ethics
Pippin, J. J., Cavanaugh, S. E., & Pistollato, F. (2019) · BRILL eBooks · doi:10.1163/9789004391192_021 · Cited by 16
Therapeutic potential of lipase inhibitor orlistat in Alzheimer’s disease
Du, J., & Wang, Z. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.04.046 · Cited by 16
“Cardiovascular risk factors, such as hypertension, hyperlipidemia, obesity and diabetes, are associated with AD risk [17–23].”
BackgroundArmstrong, M. J., Colberg, S. R., & Sigal, R. J. (2015) · Diabetes Spectrum · doi:10.2337/diaspect.28.1.14 · Cited by 17
“Studies have reported an increased risk of cognitive impairment and dementia in older patients with diabetes (70), and diabetes itself has been recognized as an independent risk factor for the development of cognitive impairment in large, prospective, population-based studies with follow-up durations of up to 18 years…”
BackgroundDiabetes, Obesity, and the Brain
Everson‐Rose, S. A., & Ryan, J. P. (2015) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000223 · Cited by 16
“Diabetes is associated with an increased risk of cognitive impairment (6) both during childhood and adolescent development and”
BackgroundHughes, T. M., Sink, K. M., Williamson, J. D., Hugenschmidt, C. E., Wagner, B., Whitlow, C. T., Xu, J., Smith, S. C., Launer, L. J., Barzilay, J. I., et al. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.05.017 · Cited by 16
Self-citationWatson, N. A., Dyer, K. A., Buckley, J. D., Brinkworth, G. D., Coates, A. M., Parfitt, G., Howe, P. R. C., Noakes, M., Dye, L., Chadwick, H. K., et al. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.11.001 · Cited by 15
Si, S.-C., Yang, W., Luo, H., Ma, Y.-X., Zhao, H., & Liu, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22956 · Cited by 15
“Diabetic patients have a 1.2-to 1.5-fold increased risk of cognitive dysfunction and a 1.6-fold increased risk of dementia compared with non-diabetic populations [16].”
BackgroundInfluentialBecker, M., Kälin, S., Neubig, A. H., Lauber, M., Opaleva, D., Hipp, H., Salb, V. K., Ott, V. B., Legutko, B., Kälin, R. E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57918-z · Cited by 17
Genetic Associations Between Fibrinogen and Cognitive Performance in Three Scottish Cohorts
Marioni, R. E., Deary, I. J., Murray, G. D., Lowe, G. D. O., Strachan, M. W. J., Michelle Luciano, A., Houlihan, L. M., Gow, A. J., Harris, S. E., Rumley, A., et al. (2011) · Behavior Genetics · doi:10.1007/s10519-011-9449-2 · Cited by 15
“People with type 2 diabetes tend to have an accelerated cognitive decline compared to those without diabetes ( Cukierman et al. 2005 ).”
BackgroundGrzęda, E., & Rj, W. (2008) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2008-1706 · Cited by 15
“…studies have reported a learning decline in subjects with diabetes, and neurophysiologic investigations have revealed conduction abnormalities in the central auditory, somatosensory, and visual pathways in diabetic individuals (Biessels and Gispen 2005, Cukierman et al. 2005, Biessels et al. 2006).”
BackgroundCognitive Impairment in People with Diabetes-Related Foot Ulceration
Siru, R., Burkhardt, M. S., Davis, W. A., Hiew, J., Manning, L. A., Ritter, J. C., Norman, P. E., Makepeace, A., Fegan, P. G., Bruce, D. G., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132808 · Cited by 15
“Diabetes is an established risk factor for cognitive dysfunction and dementia [14,15]; these can occur relatively early in type 2 diabetes [16] and they share common risk factors with foot ulceration [17], such as hypertension [18], obesity, poor glycaemic control, diabetic retinopathy [19], and cerebrovascular diseas…”
BackgroundÇelik, G., Annagür, B. B., Yılmaz, M., & Kara, F. (2012) · PubMed Central · Cited by 15
Evaluating Older Patients with Diabetes for Insulin Pump Therapy
Stephens, E. A., & Heffner, J. E. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0024 · Cited by 15
“Because patients with diabetes are at greater risk of dementia as they age compared to age-matched individuals without diabetes 23 and because cognitive decline may develop abruptly, the diabetes team must be ready to perform a comprehensive assessment of a patient’s abilities to manage a pump when…”
Peter, E. L., Nagendrappa, P. B., Kaligirwa, A., Ogwang, P. E., & Sesaazi, D. C. (2020) · Phytotherapy Research · doi:10.1002/ptr.6853 · Cited by 14
Core Neuropsychological Measures for Obesity and Diabetes Trials: Initial Report
D’Ardenne, K., Savage, C. R., Small, D. M., Vainik, U., & Stoeckel, L. E. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.554127 · Cited by 14
“Performance on various digit symbol matching tests has been consistently linked with obesity and diabetes (Brands et al., 2005; Cukierman et al., 2005; Cournot et al., 2006; Palta et al., 2014).”
BackgroundYuan, Y., Zhang, Y., Lei, M., Guo, X., Yang, X., Ouyang, C., Liu, C., & Chen, Q. (2024) · International Journal of Endocrinology · doi:10.1155/2024/9294113 · Cited by 14
Pavlik, V., Massman, P. J., Barber, R. C., & Doody, R. S. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121999 · Cited by 14
“Numerous clinical and epidemiological studies have shown a relationship between high levels of peripheral insulin and risk of cognitive impairment and/or dementia in initially cognitively normal individuals [1–10].”
Lin, H., Yuan, Y., Tian, S., Han, J., Huang, R., Guo, D., Wang, J., An, K., & Wang, S. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00634 · Cited by 14
Impact of metabolic dysfunction on cognition in humans
Rasmussen, I. J., Thomassen, J. Q., & Frikke‐Schmidt, R. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000723 · Cited by 14
Relationship between cognitive function in individuals with diabetic foot ulcer and mortality
Sela, Y., Grinberg, K., Cukierman‐Yaffe, T., & Natovich, R. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00901-1 · Cited by 14
“6-fold higher risk of future dementia compared to those without DM [12].”
BackgroundAxonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy
Svenningsson, A. L., Stomrud, E., Palmqvist, S., Hansson, O., & Ossenkoppele, R. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01081-w · Cited by 14
“Previous studies have shown associations for diabetes mellitus [25], congestive heart failure [26], and stroke [27, 28], with risk of cognitive decline and dementia, but there are few studies investigating the association when accounting for brain atrophy.”
BackgroundResultWalter, K. R., Ricketts, D. K., Presswood, B. H., Smith, S. M., & Mooney, S. M. (2022) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2022.2119571 · Cited by 17
Zhao, F., Tomita, M., & Dutta, A. (2023) · Brain Sciences · doi:10.3390/brainsci13071099 · Cited by 14
Glycemic Targets and Medication Limitations for Type 2 Diabetes Mellitus in the Older Adult
Thompson, A. M., Linnebur, S. A., Griend, J. P. V., & Saseen, J. J. (2014) · The Consultant Pharmacist · doi:10.4140/tcp.n.2014.110 · Cited by 15
Lu, K., Li, M., Yuan, J., & Wu, J. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4293 · Cited by 14
“Cross-sectional and prospective studies indicated that diabetes is associated with cognitive impairment involving both executive and memory functions (Bruce et al., 2003; Wu et al., 2003; Cukierman et al., 2005; van den Berg et al., 2006; Trento et al., 2012; Garcia-Casares et al., 2014).”
BackgroundZhang, Y., Liu, H., Chen, Z., Yu, M., Li, J., Dong, H., Li, N., Ding, X., Ge, Y., Liu, C., et al. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104818 · Cited by 14
Offspring Study of Racial and Ethnic Disparities in Alzheimer’s Disease: Objectives and DesignPreprint
Manly, J. J., Rentería, M. A., Avila‐Rieger, J. F., Turney, I. C., Vonk, J. M. J., Lao, P. J., Šeblová, D., Fleurimont, J., Martinez, M. N., & Brickman, A. M. (2020) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/frbkj · Cited by 13
Diabetes Technology and the Older Adult: Clinical Outcomes and Implementation Strategies
Urbina, K. L., Slyne, C., & Munshi, M. N. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.08.004 · Cited by 14
The Incidence and Management of Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus
Ikoh, C. L., & Tinong, R. T. (2023) · Cureus · doi:10.7759/cureus.44468 · Cited by 20
“GDM women rarely show any symptoms; however, excessive thirst and increased urination can occur in some cases [18].”
Background“Brittleness” in Diabetes: Easier Spoken than Broken
Voulgari, C., Pagoni, S., Paximadas, S., & Vinik, A. I. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0058 · Cited by 13
“50 Furthermore, in the presence of otherwise unexplained BD, the coexistence of iron-deficiency anemia should give rise to suspicion of celiac disease because it is its commonest extraintestinal manifestation.”
InfluentialCui, D. Y., Wang, J., Bian, Z., Li, Q., Wang, L., & Xiaoli Li, A. (2014) · Journal of Innovative Optical Health Sciences · doi:10.1142/s1793545815500108 · Cited by 13
Adeyi, A. O., Lotanna, M. N., & Idowu, B. A. (2015) · Journal of Medicinal Plants Research · doi:10.5897/jmpr2014.5662 · Cited by 13
“Other chronic complications of diabetes include depression (Nouwen et al., 2011), dementia (Cukierman et al., 2005), and sexual dysfunction (Adeniyi et al., 2011).”
Lotan, R., Ganmore, I., Shelly, S., Zacharia, M., Uribarri, J., Beisswenger, P. J., Cai, W., Troen, A. M., & Beeri, M. S. (2020) · Nutrients · doi:10.3390/nu12103143 · Cited by 13
“T2D has been consistently shown to increase the risk ofAD [13]; diabetic individuals have relatively high levels of AGEs, in part due to high circulating glucose levels.”
BackgroundQian, H., Qin, D., Qi, S., Teng, Y., Li, C., Yao, Y., & Wu, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.588684 · Cited by 12
Lee, S. L., Kim, T. D., Kim, R. Y., Joo, Y., Chung, Y., Lim, S. M., Lyoo, I. K., Kim, J., & Yoon, S. J. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15505 · Cited by 13
Mild Cognitive Impairment in the Elderly
Энгманн, Б. (2011) · GeroPsych · doi:10.1024/1662-9647/a000036 · Cited by 15
Maviş, İ., Adapınar, B. D. Ö., Yenilmez, Ç., Aydin, A., OLGUN, E., & Bal, C. (2015) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1405-120 · Cited by 13
Metabolic pathways in the periphery and brain: Contribution to mental disorders?
Nagalski, A., Koziński, K., & Wisniewska, M. B. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.09.012 · Cited by 14
Beneficial effects of yogasanas and pranayama in limiting the cognitive decline in Type 2 diabetes
Nagothu, R., Archana, R., Indla, Y. R., & Paluru, R. (2016) · National Journal of Physiology Pharmacy and Pharmacology · doi:10.5455/njppp.2017.7.0825508092016 · Cited by 13
“Scores from 88 to 83 are considered with mild cognitive impairment and scores ≤82 are with dementia.[5] ACE and ACE-R were been translated into many languages worldwide, including Indian regional languages such as Malayalam,[9] Hindi, and Telugu, and thus, these translations are useful in assessing the cognition in a…”
García‐Hermoso, A., Ramírez‐Vélez, R., Ramírez‐Campillo, R., & Izquierdo, M. (2017) · Rejuvenation Research · doi:10.1089/rej.2017.1984 · Cited by 14
“35 Regarding physical activity (the parameter most strongly related to cognition function), several studies 36,37 have shown that physical activity might prevent cognitive decline and neuro-degenerative diseases in older adults, even when accounting for potential confounders such as age, sex,…”
Ye, S., Xie, D., Zhou, P., Gao, H., Zhang, M., Chen, D., Qin, Y.-P., Lei, X., Li, X., Liu, J., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5514175 · Cited by 13
“A large number of epidemiological studies showed that diabetes mellitus is prone to cognitive decline and dementia [24, 25], whether it is type 1 diabetes or type 2 diabetes.”
BackgroundDiabetes Management and Hyperglycemia in Safety Sensitive Jobs
Lee, S. M., Koh, D. S. Q., Fun, S., & Sum, C.-F. (2011) · Safety and Health at Work · doi:10.5491/shaw.2011.2.4.380 · Cited by 13
Memantine Prevents Hypoglycemia-Induced Decrements of the Cerebral Energy Status in Healthy Subjects
Willenborg, B., Schmoller, A., Caspary, J., Melchert, U. H., Scholand-Engler, H. G., Jauch‐Chara, K., Hohagen, F., Schweiger, U., & Oltmanns, K. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1348 · Cited by 13
Barzilay, J. I., Ghosh, A., Pop‐Busui, R., Ahmann, A., Balasubramanyam, A., Banerji, M. A., Cohen, R. M., Green, J., Ismail‐Beigi, F., Martin, C. L., et al. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108047 · Cited by 12
Su, J., Sun, G., An, J., Ao, Y., Li, J., Shen, Z., Zhang, L., Zhang, S., Yang, Y., & Shi, Y. X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1280736 · Cited by 12
Cui, D. Y., Liu, J., Bian, Z., Li, Q., Wang, L., & Xiaoli Li, A. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/523216 · Cited by 12
“6 times greater risk of future dementia than individuals without diabetes [11].”
BackgroundFactores de riesgo vascular y enfermedad de Alzheimer
Doña, P. J. R., Artigas, P. D. A., Guerra, M. L. S., & Monfort, C. A. (2009) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2008.12.004 · Cited by 15
Clinical Features of Geriatric Syndromes in Older Koreans with Diabetes Mellitus
Moon, S., Roh, Y. K., Yoon, J. L., Jang, K. U., Jung, H. J., Yoo, H. J., Jang, H. C., & Geriatric Syndromes Study Group of Korea Geriatrics Society (2019) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.19.0041 · Cited by 12
Sajan, M. P., HANSEN, B. C., Acevedo-Duncan, M. E., Kindy, M. S., Cooper, D. R., & Farese, R. V. (2021) · MedComm · doi:10.1002/mco2.54 · Cited by 12
Lu, H., Liu, J., Gu, G., Xiaoli Li, A., Yin, S., & Cui, D. Y. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.07.022 · Cited by 12
New Evidence of Central Nervous System Damage in Diabetes: Impairment of Fine Visual Discrimination
Chen, H., Wang, M., Xia, L., Dong, J., Xu, G., Wang, Z., Feng, L., & Zhou, Y. (2022) · Diabetes · doi:10.2337/db21-0715 · Cited by 12
MiR-146a-5p Contributes to Microglial Polarization Transitions Associated With AGEs
Huang, Y., Lin, X., & Lin, X. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03252-8 · Cited by 12
“Its clinical manifestations are memory decline, attention decline, abstract thinking and reasoning ability decline, and visual dysfunction, and serious cases may develop dementia [1].”
BackgroundJiang, X., Zhao, X., Chen, R., Jiang, Q., & Zhou, B. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.60821 · Cited by 12
Chomová, M., Balážová, M., & Muchová, J. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3061-6 · Cited by 12
Cukierman‐Yaffe, T., Gerstein, H. C., Miller, M. E., Launer, L. J., Williamson, J. D., Horowitz, K. R., Ismail‐Beigi, F., & Lazar, R. M. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3480 · Cited by 12
Self-citationKumar, N., Singh, V., Meena, B., Kumar, D., Kumar, H., Saini, M., & Tiwari, A. K. (2018) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_58_18 · Cited by 11
Mehra, A., Sangwan, G., Grover, S., Kathirvel, S., & Avasthi, A. (2020) · Journal of Neurosciences in Rural Practice · doi:10.1055/s-0040-1715540 · Cited by 12
Aberle, I., Kliegel, M., & Zimprich, D. (2008) · Current Psychology · doi:10.1007/s12144-008-9020-3 · Cited by 12
Indja, B., Fanning, J. P., Maller, J. J., Fraser, J. F., Bannon, P. G., Vallely, M. P., & Grieve, S. M. (2017) · British Journal of Anaesthesia · doi:10.1093/bja/aex088 · Cited by 12
Rotonen, S., AUVINEN, J. P., Bloigu, A. H., Härkönen, P. K., Jokelainen, J. J., Timonen, M., & Keinanen-Kiukaanniemi, S. M. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109045 · Cited by 11
Shao, P., Li, X., Qin, R., Xu, H., Sheng, X., Huang, L., Ma, J., Cheng, Y., Chen, H., Zhang, B., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.934071 · Cited by 11
“However, T2DM promotes the progression of MCI to more severe stages, such as dementia (Cukierman et al., 2005).”
BackgroundSrivastava, A., Adem, K. A., Shanti, A., Lee, S., Abedrabbo, S. M., & Homouz, D. (2024) · ACS Omega · doi:10.1021/acsomega.4c00500 · Cited by 11
Demencia y diabetes: ¿relación casual o causal?
Formiga, F., Reñé, R., & Pérez-Maraver, M. (2014) · Medicina Clínica · doi:10.1016/j.medcli.2014.01.026 · Cited by 13
Aghajanpour-Mir, M., Amjadi‐Moheb, F., Dadkhah, T., Hosseini, S. R., Ghadami, E., Assadollahi, E., Akhavan‐Niaki, H., & Ahangar, A. A. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4561-5 · Cited by 12
Wong, C. W., Wai‐Tsun William, O., Wong, K. S., Ronald, C. W., Hui, E., & Kwok, C. T. (2020) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14062 · Cited by 11
Al‐Onaizi, M., Al-Sarraf, A. J., Braysh, K., Kazem, F., Al‐Hussaini, H., Rao, M. S. R., Kilarkaje, N., & ElAli, A. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15835 · Cited by 11
Cohn‐Schwartz, E., Joshi, R., & McClure, L. A. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20031885 · Cited by 12
“8-fold greater risk of cognitive impairment and are at an increased risk for accelerated cognitive decline [10,16,17], possibly due to the chronic exposure of the brain to high levels of glucose or due to insufficient insulin action in the brain [10].”
BackgroundBiomarkers of Renal Function in Type 2 Diabetic Patients with Cognitive Impairment
Zhang, J., Geng, N., Li, Z., Qiao, H.-J., Sun, H., & Li, F. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.10.059 · Cited by 11
Jing, G., Zhang, M., Ji, C., Zuo, P., Liu, Y., & Gu, B. (2016) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-016-2256-0 · Cited by 12
“It is associated with an increased risk of cognitive, learning and memory impairment in older age, and a higher incidence of dementia.((2-5)) These complications of both type 1 and type 2 DM may be called as 'diabetic encephalopathy', a concept introduced several decades ago.”
BackgroundLee, C., Lui, D. T. W., Cheung, C. Y. Y., Woo, Y. C., Fong, C. H.-Y., Yuen, M. M. A., Shea, Y. F., Siu, D. C. W., Chan, K., Chow, W., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3401 · Cited by 11
“3‐fold greater risk of developing Alzheimer's disease (AD), over a follow‐up of 2–7 years, compared to those without diabetes.(2) A recent meta‐analysis also reported a 1.”
BackgroundInterhemispheric resting-state functional connectivity abnormalities in type 2 diabetes patients
Zhang, Y., Wang, J., Wei, P., Zhang, J., Zhang, G., Pan, C., Yufen, Z., Sun, X., & Cui, J. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-1655 · Cited by 11
“T2DM is associated with cognitive impairment (3,4), which typically symptoms manifests as a decline in memory, attention, information processing speed (5), and executive function (6).”
BackgroundWang, J., Ma, L., Liu, G., Bai, W., Ai, K., Zhang, P., Hu, W., & Zhang, J. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.800420 · Cited by 11
Epidemiology of Alzheimer’s Disease
Xu, W., Ferrari, C., & Wang, H. (2013) · InTech eBooks · doi:10.5772/54398 · Cited by 18
Gul, C. B., Gül, Ö. Ö., Cander, S., Eroğlu, A., Hartavi, M., Keni, N., Bayindir, A., Ersoy, C., Ertürk, E., Tuncel, E., et al. (2014) · Renal Failure · doi:10.3109/0886022x.2014.938576 · Cited by 11
“Various studies have reported that diabetes in elderly individuals is associated with reduced cognitive functions.(10,11) Cukierman et al.”
BackgroundInfluentialChen, Z., Xiujuan, Z., Liu, M., Liu, M., Li, J., Gu, Z., & Ma, L. (2017) · Chinese Medical Sciences Journal · doi:10.24920/j1001-9294.2017.010 · Cited by 11
“The main imaging process was as follows:19 (1) Using N3 algorithm to correct the filed inhomogeneity, and using a hybrid watershed algorithm to remove the non-brain tissues;20 (2) subcortical white matter and gray matter segmentation with automatic Talairach transformation;22-23 (3) generating the gray/white matter su…”
MethodCao, W., Tian, S., Zhang, H., Zhu, W., An, K., Shi, J., Yuan, Y., & Wang, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00743 · Cited by 10
“Moreover, T2DM is an independent risk factor for MCI and promotes progression to dementia (Cukierman et al., 2005).”
BackgroundPotential Role of Yoga in Management of the Ominous Octet
Vijayakumar, V., Mavathur, R. N., Raguram, N., Ranjani, H., Anjana, R. M., & Mohan, V. (2021) · Journal of Diabetology · doi:10.4103/jod.jod_6_18 · Cited by 12
Xiao, H., Zhang, F.-R., Li, S., Guo, F., Jin-li, H., Wang, S.-C., Yu, J., Li, X., & Yang, H. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116219 · Cited by 10
Low serum apelin levels are associated with mild cognitive impairment in Type 2 diabetic patients
Jiang, Y., Wang, S., & Liu, X. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01051-1 · Cited by 10
Hayden, M. R. (2024) · Biomedicines · doi:10.3390/biomedicines12010096 · Cited by 13
McLaughlin, A. C., Whitlock, L. A., Lester, K. L., & McGraw, A. E. (2015) · Journal of Health Psychology · doi:10.1177/1359105315603472 · Cited by 12
“Based on their ages, those in the sample approximated the knowledge levels and age of a typical person newly diagnosed with type 2 diabetes (Table 1; Cukierman et al., 2005).”
BackgroundElfassy, T., Aiello, A. E., Schneiderman, N., Haan, M. N., Tarraf, W., González, H. M., Gellman, M. D., Florez, H. J., Luchsinger, J. A., Wright, C. B., et al. (2018) · Journal of Aging and Health · doi:10.1177/0898264318759379 · Cited by 10
Andrews, R. M., Shpitser, I., López, O. L., Longstreth, W. T., Jr., Chaves, P. H. M., Kuller, L. H., & Carlson, M. C. (2020) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.1111/rssa.12570 · Cited by 10
“In general, our results fit within the broader literature showing that diabetics have a significantly greater risk of accelerated cognitive decline and cognitive impairment compared with non-diabetics (Cheng et al., 2012; Cukierman et al., 2005; Mayeda et al., 2015; Palta et al., 2017).”
BackgroundResultZhan, C., Wang, Q., Liu, J., Wang, L., Chen, Z., Pang, H., Tu, J., Ning, X., Wang, J., & Fei, S. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s308250 · Cited by 10
Metadata
- Authors
- Cukierman, T., Gerstein, H. C., & Williamson, J. D.
- Affiliations
- Population Health Research Institute (CA)
- Wake Forest University Health Sciences (US)
- Corresponding author
- Cukierman, T.
- Venue
- Diabetologia
- Published
- 2005-11-08
- Volume
- 48
- Issue
- 12
- Pages
- 2460-2469
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2046949772
- Cited by
- 1,049
- References
- 90
- Citations by year
- 2026: 23 · 2025: 47 · 2024: 37 · 2023: 56 · 2022: 72 · 2021: 58 · 2020: 62 · 2019: 70 · 2018: 54 · 2017: 61 · 2016: 65 · 2015: 67 · 2014: 77 · 2013: 64 · 2012: 43
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- diabetes mellitus, cognitive decline, dementia, cognitive function, Mini-Mental State Examination, Digit Symbol Substitution Test, chronic complications of diabetes, longitudinal cohort
- MeSH terms
- Cognition, Cognition Disorders, Dementia, Diabetes Mellitus, Follow-Up Studies, Humans, Intelligence Tests, Longitudinal Studies, Neuropsychological Tests, Prospective Studies, Risk Factors, Odds Ratio, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
